These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15289816)

  • 1. Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.
    Zhang PW; Ishiguro H; Ohtsuki T; Hess J; Carillo F; Walther D; Onaivi ES; Arinami T; Uhl GR
    Mol Psychiatry; 2004 Oct; 9(10):916-31. PubMed ID: 15289816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence.
    Herman AI; Kranzler HR; Cubells JF; Gelernter J; Covault J
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jul; 141B(5):499-503. PubMed ID: 16741937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions.
    Drgon T; D'Addario C; Uhl GR
    Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):854-60. PubMed ID: 16894595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.
    Clarke TK; Bloch PJ; Ambrose-Lanci LM; Ferraro TN; Berrettini WH; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Lohoff FW
    Addict Biol; 2013 Jul; 18(4):702-8. PubMed ID: 21790903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample.
    Zuo L; Kranzler HR; Luo X; Yang BZ; Weiss R; Brady K; Poling J; Farrer L; Gelernter J
    Neuropsychopharmacology; 2009 May; 34(6):1504-13. PubMed ID: 19052543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association of CNR1 gene variations with susceptibility to schizophrenia.
    Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
    Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNR1 variation modulates risk for drug and alcohol dependence.
    Zuo L; Kranzler HR; Luo X; Covault J; Gelernter J
    Biol Psychiatry; 2007 Sep; 62(6):616-26. PubMed ID: 17509535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
    Ho BC; Wassink TH; Ziebell S; Andreasen NC
    Schizophr Res; 2011 May; 128(1-3):66-75. PubMed ID: 21420833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
    Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
    Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1.
    Proudnikov D; Kroslak T; Sipe JC; Randesi M; Li D; Hamon S; Ho A; Ott J; Kreek MJ
    Pharmacogenomics J; 2010 Jun; 10(3):232-42. PubMed ID: 20010914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis.
    Benyamina A; Kebir O; Blecha L; Reynaud M; Krebs MO
    Addict Biol; 2011 Jan; 16(1):1-6. PubMed ID: 20192949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour.
    Hay EA; McEwan A; Wilson D; Barrett P; D'Agostino G; Pertwee RG; MacKenzie A
    Psychoneuroendocrinology; 2019 Nov; 109():104407. PubMed ID: 31445429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population.
    Bae JS; Kim JY; Park BL; Kim JH; Kim B; Park CS; Kim BJ; Lee CS; Lee M; Choi WH; Shin TM; Hwang J; Shin HD; Woo SI
    Psychiatr Genet; 2014 Oct; 24(5):225-9. PubMed ID: 25014618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence.
    Agrawal A; Wetherill L; Dick DM; Xuei X; Hinrichs A; Hesselbrock V; Kramer J; Nurnberger JI; Schuckit M; Bierut LJ; Edenberg HJ; Foroud T
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jul; 150B(5):736-40. PubMed ID: 19016476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
    Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
    Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects.
    Gelernter J; Kranzler H; Cubells JF
    Hum Genet; 1997 Dec; 101(2):243-6. PubMed ID: 9402979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue-specific activity of the cannabinoid-1 receptor gene promoter; implications for cannabinoid pharmacogenetics.
    Hay EA; Cowie P; McEwan AR; Ross R; Pertwee RG; MacKenzie A
    Hum Mutat; 2020 Jan; 41(1):291-298. PubMed ID: 31608546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.
    Yuferov V; Fussell D; LaForge KS; Nielsen DA; Gordon D; Ho A; Leal SM; Ott J; Kreek MJ
    Pharmacogenetics; 2004 Dec; 14(12):793-804. PubMed ID: 15608558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin Promoter Factor 1 variation is associated with type 2 diabetes in African Americans.
    Karim MA; Wang X; Hale TC; Elbein SC
    BMC Med Genet; 2005 Oct; 6():37. PubMed ID: 16229747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence variation and linkage disequilibrium in the GABA transporter-1 gene (SLC6A1) in five populations: implications for pharmacogenetic research.
    Hirunsatit R; Ilomäki R; Malison R; Räsänen P; Ilomäki E; Kranzler HR; Kosten T; Sughondhabirom A; Thavichachart N; Tangwongchai S; Listman J; Mutirangura A; Gelernter J; Lappalainen J
    BMC Genet; 2007 Oct; 8():71. PubMed ID: 17941974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.